Plain-English translation of NCT05341141 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Read our Breast Cancer research guide โThis study doesn't follow the usual testing phases โ it may be an observational study or a different type of research.
This trial is testing whether a simple technique using cold therapy (frozen gloves and socks) combined with compression therapy (tight surgical gloves) can prevent a serious side effect called peripheral neuropathy. Peripheral neuropathy is nerve damage that causes numbness, tingling, and pain in the hands and feet โ a common problem for patients receiving albumin-paclitaxel chemotherapy for HER-2 negative breast cancer. Half of the participants will receive the cooling and compression treatment during their chemotherapy infusions, while the other half will receive standard chemotherapy alone.
Albumin-paclitaxel is an effective chemotherapy, but it often damages nerves in the hands and feet, sometimes causing permanent pain and disability. Researchers want to know if keeping your hands and feet very cold during treatment can reduce or prevent this nerve damage, which would significantly improve quality of life for cancer patients.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you are randomly selected to receive the cooling and compression treatment, you will wear special frozen gloves and socks for 15 minutes before, during, and 15 minutes after each chemotherapy infusion with albumin-paclitaxel. You will also wear compression gloves for 30 minutes before, during, and 30 minutes after the same infusions. If you are in the standard care group, you will receive the same chemotherapy without the cooling and compression. Throughout the study, your medical team will monitor you closely for any signs of nerve damage using standard assessments.
AI-generated summary from trial data ยท Jun 7, 2026 ยท Not medical advice
China